Patents by Inventor Peter J. Facchini

Peter J. Facchini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTI-SUBSTITUENT PSILOCYBIN DERIVATIVES AND METHODS OF USING
    Publication number: 20240122950
    Abstract: Disclosed are novel multi-substituent psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a substituent containing compound.
    Type: Application
    Filed: December 20, 2023
    Publication date: April 18, 2024
    Inventors: Jillian M. Hagel, Peter J. Facchini, Chang-Chun Ling
  • AMINATED PSILOCYBIN DERIVATIVES AND METHODS OF USING
    Publication number: 20240116866
    Abstract: Disclosed are novel aminated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The aminated psilocybin derivative compounds may be chemically synthesized.
    Type: Application
    Filed: November 16, 2023
    Publication date: April 11, 2024
    Inventors: Jillian M. Hagel, Peter J. Facchini, Chang-Chun Ling
  • FUSED HETEROCYCLIC MESCALINE DERIVATIVES
    Publication number: 20240116907
    Abstract: Disclosed are novel fused heterocyclic mescaline derivative compounds, notably fused heterocyclic mescaline derivatives and pharmaceutical and recreational drug formulations containing the same. Methods of making and using these compounds are also disclosed.
    Type: Application
    Filed: August 4, 2023
    Publication date: April 11, 2024
    Inventors: Peter J. Facchini, Jillian M. Hagel, Chang-Chun Ling, Charlie Cai, David James Press, Glynnis Elizabeth Jensen, Jessica Bik-Jing Lee, Kaveh Matinkhoo
  • C-carbonothioate-substituted tryptamine derivatives and methods of using
    Patent number: 11945778
    Abstract: Disclosed are novel C4-carbonothioate-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
    Type: Grant
    Filed: May 31, 2023
    Date of Patent: April 2, 2024
    Assignee: Enveric Biosciences Canada Inc.
    Inventors: Jillian M. Hagel, Kaveh Matinkhoo, Peter J. Facchini
  • Nitrilated psilocybin derivatives and methods of using
    Patent number: 11931338
    Abstract: Disclosed are novel nitrilated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a nitrile-group containing compound.
    Type: Grant
    Filed: September 16, 2022
    Date of Patent: March 19, 2024
    Assignee: Enveric Biosciences Canada Inc.
    Inventors: Jillian M. Hagel, Peter J. Facchini, Chang-Chun Ling
  • Multi-substituent psilocybin derivatives and methods of using
    Patent number: 11918594
    Abstract: Disclosed are novel multi-substituent psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a substituent containing compound.
    Type: Grant
    Filed: September 29, 2022
    Date of Patent: March 5, 2024
    Assignee: Enveric Biosciences Canada Inc.
    Inventors: Jillian M. Hagel, Peter J. Facchini, Chang-Chun Ling
  • Prenylated psilocybin derivatives and methods of using
    Patent number: 11891359
    Abstract: Disclosed are novel prenylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced in vitro or in vivo using a biosynthetic system which comprises cells comprising a prenyl transferase, and, optionally, additional enzymes, including a decarboxylase, and an N-acetyl transferase.
    Type: Grant
    Filed: September 29, 2022
    Date of Patent: February 6, 2024
    Assignee: ENVERIC BIOSCIENCES CANADA INC.
    Inventors: Jillian M. Hagel, Peter J. Facchini, Xue Chen
  • Glycosylated psilocybin derivatives and methods of using
    Patent number: 11891360
    Abstract: Disclosed are novel glycosylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a hydroxylated psilocybin derivative with a glycosyl compound.
    Type: Grant
    Filed: September 9, 2022
    Date of Patent: February 6, 2024
    Assignee: Enveric Biosciences Canada Inc.
    Inventors: Jillian M. Hagel, Peter J. Facchini, Chang-Chun Ling
  • Aminated psilocybin derivatives and methods of using
    Patent number: 11858895
    Abstract: Disclosed are novel aminated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The aminated psilocybin derivative compounds may be chemically synthesized.
    Type: Grant
    Filed: September 16, 2022
    Date of Patent: January 2, 2024
    Assignee: Enveric Biosciences Canada Inc.
    Inventors: Jillian M. Hagel, Peter J. Facchini, Chang-Chun Ling
  • C-carbonothioate-substituted tryptamine derivatives and methods of using
    Patent number: 11845726
    Abstract: Disclosed are novel C4-carbonothioate-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
    Type: Grant
    Filed: August 22, 2022
    Date of Patent: December 19, 2023
    Assignee: ENVERIC BIOSCIENCES CANADA INC.
    Inventors: Jillian M. Hagel, Kaveh Matinkhoo, Peter J. Facchini
  • Aldehyde and ketone derivatives of psilocybin and methods of using
    Patent number: 11845727
    Abstract: Disclosed are novel aldehyde and ketone psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with an aldehyde or ketone group containing compound.
    Type: Grant
    Filed: September 23, 2022
    Date of Patent: December 19, 2023
    Assignee: ENVERIC BIOSCIENCES CANADA INC.
    Inventors: Jillian M. Hagel, Peter J. Facchini, Chang-Chun Ling
  • CARBOXYLATED PSILOCYBIN DERIVATIVES AND METHODS OF USING
    Publication number: 20230398097
    Abstract: Disclosed are novel carboxylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a carboxyl or Carboxylic acid derivative containing compound.
    Type: Application
    Filed: July 28, 2023
    Publication date: December 14, 2023
    Inventors: Jillian M. Hagel, Peter J. Facchini, Chang-Chun Ling
  • NEOPINONE ISOMERASE AND METHODS OF USING
    Publication number: 20230357810
    Abstract: Disclosed are methods for converting a first morphinan alkaloid compound into a second morphinan alkaloid compound in the presence of a neopinone isomerase enzyme under reaction conditions permitting the conversion of the first alkaloid compound into the second alkaloid compound. The first alkaloid compound can be neopinone or neomorphinone. The second alkaloid compound can be codeinone or morphinone. Related compositions are also disclosed.
    Type: Application
    Filed: December 22, 2022
    Publication date: November 9, 2023
    Inventors: Peter J. FACCHINI, Xue CHEN
  • C4-CARBOXYLIC ACID-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING
    Publication number: 20230357185
    Abstract: Disclosed are novel C4-carboxylic acid-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
    Type: Application
    Filed: August 11, 2022
    Publication date: November 9, 2023
    Inventors: Jillian M. Hagel, Ye Cai, Kaveh Matinkhoo, David James Press, Glynnis Elizabeth Jensen, Peter J. Facchini
  • C4-CARBOXYLIC ACID-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING
    Publication number: 20230357145
    Abstract: Disclosed are novel C4-carboxylic acid-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
    Type: Application
    Filed: July 5, 2023
    Publication date: November 9, 2023
    Inventors: Jillian M. Hagel, Ye Cai, Kaveh Matinkhoo, David James Press, Glynnis Elizabeth Jensen, Peter J. Facchini
  • C4-CARBONOTHIOATE-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING
    Publication number: 20230321040
    Abstract: Disclosed are novel C4-carbonothioate-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
    Type: Application
    Filed: May 31, 2023
    Publication date: October 12, 2023
    Inventors: Jillian M. Hagel, Kaveh Matinkhoo, Peter J. Facchini
  • C4-CARBONOTHIOATE-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING
    Publication number: 20230295085
    Abstract: Disclosed are novel C4-carbonothioate-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
    Type: Application
    Filed: August 22, 2022
    Publication date: September 21, 2023
    Inventors: Jillian M. Hagel, Kaveh Matinkhoo, Peter J. Facchini
  • C4-CARBOXYLIC ACID-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING
    Publication number: 20230295084
    Abstract: Disclosed are novel C4-carboxylic acid-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
    Type: Application
    Filed: August 11, 2022
    Publication date: September 21, 2023
    Inventors: Jillian M. Hagel, Ye Cai, Kaveh Matinkhoo, David James Press, Glynnis Elizabeth Jensen, Peter J. Facchini
  • HALOGENATED PSILOCYBIN DERIVATIVES AND METHODS OF USING
    Publication number: 20230293558
    Abstract: Disclosed are novel halogenated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced using a biosynthetic system which comprises cells comprising a psilocybin biosynthetic enzyme complement.
    Type: Application
    Filed: September 6, 2022
    Publication date: September 21, 2023
    Inventors: Jillian M. Hagel, Peter J. Facchini
  • Carboxylated psilocybin derivatives and methods of using
    Patent number: 11752130
    Abstract: Disclosed are novel carboxylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a carboxyl or Carboxylic acid derivative containing compound.
    Type: Grant
    Filed: September 23, 2022
    Date of Patent: September 12, 2023
    Assignee: Enveric Biosciences Canada Inc.
    Inventors: Jillian M. Hagel, Peter J. Facchini, Chang-Chun Ling